Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis.
about
Levosimendan protects human hepatocytes from ischemia-reperfusion injury.Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.The effect of levosimendan in rat mesenteric ischemia/reperfusion injury.Beneficial pharmacological effects of levosimendan on antioxidant status of acute inflammation induced in paw of rat: involvement in inflammatory mediators.Assessment of the effects of levosimendan and thymoquinone on lung injury after myocardial ischemia reperfusion in rats.
P2860
Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis.
@en
type
label
Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis.
@en
prefLabel
Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis.
@en
P2093
P2860
P356
P1476
Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis.
@en
P2093
Aira Heikkilä
Antti Saraste
Christoffer Stark
Juha W Koskenvuo
Jussi P Pärkkä
Kari Leino
Markus Malmberg
Pekka Saukko
Timo Laitio
Timo Savunen
P2860
P356
10.3389/FPHYS.2012.00017
P577
2012-02-14T00:00:00Z